Behavioral Changes in Huntington Disease
- PMID: 29561317
- PMCID: PMC6005379
- DOI: 10.1097/WNN.0000000000000147
Behavioral Changes in Huntington Disease
Abstract
To mark the 30th anniversary of Cognitive and Behavioral Neurology (which was titled Neuropsychiatry, Neuropsychology, and Behavioral Neurology from 1988 to 2002), the editors have identified several articles previously published in the journal that might be termed “classics” in the field. These articles will be reprinted in the four issues to appear in 2018, each with a brief commentary by a contemporary working in that subject area. The aim of this project is to highlight the progress made in our subspecialty during the past few decades. Here, Jason Brandt introduces one of two articles reprinted in the current issue: Craufurd D, Thompson JC, Snowden JS. 2001. Behavioral changes in Huntington disease.
Conflict of interest statement
The commentator declares no conflicts of interest.
Comment on
-
Behavioral changes in Huntington Disease.Neuropsychiatry Neuropsychol Behav Neurol. 2001 Oct-Dec;14(4):219-26. Neuropsychiatry Neuropsychol Behav Neurol. 2001. PMID: 11725215
Similar articles
-
Short-term effects of olanzapine in Huntington disease.Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jan;14(1):69-72. Neuropsychiatry Neuropsychol Behav Neurol. 2001. PMID: 11234911
-
Behavioral changes in Huntington Disease.Neuropsychiatry Neuropsychol Behav Neurol. 2001 Oct-Dec;14(4):219-26. Neuropsychiatry Neuropsychol Behav Neurol. 2001. PMID: 11725215
-
Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.Clin Neuropharmacol. 2011 May-Jun;34(3):95-100. doi: 10.1097/WNF.0b013e31821c31d8. Clin Neuropharmacol. 2011. PMID: 21586914 Clinical Trial.
-
Nonmotor Symptoms in Huntington Disease.Int Rev Neurobiol. 2017;134:1397-1408. doi: 10.1016/bs.irn.2017.05.004. Epub 2017 Jun 1. Int Rev Neurobiol. 2017. PMID: 28805577 Review.
-
Making a measurable difference in advanced Huntington disease care.Handb Clin Neurol. 2017;144:183-196. doi: 10.1016/B978-0-12-801893-4.00016-X. Handb Clin Neurol. 2017. PMID: 28947117 Review.
Cited by
-
Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.Cells. 2020 Dec 8;9(12):2642. doi: 10.3390/cells9122642. Cells. 2020. PMID: 33302607 Free PMC article.
-
Absence of hippocampal pathology persists in the Q175DN mouse model of Huntington's disease despite elevated HTT aggregation.J Huntingtons Dis. 2025 Feb;14(1):59-84. doi: 10.1177/18796397251316762. Epub 2025 Feb 3. J Huntingtons Dis. 2025. PMID: 39973391 Free PMC article.
-
Endophytic fungi: a potential source for drugs against central nervous system disorders.Braz J Microbiol. 2023 Sep;54(3):1479-1499. doi: 10.1007/s42770-023-00997-1. Epub 2023 May 11. Braz J Microbiol. 2023. PMID: 37165297 Free PMC article. Review.
References
-
- Brandt J, Folstein SE, Folstein MF. 1988. Differential cognitive impairment in Alzheimer’s disease and Huntington’s disease. Ann Neurol. 23:555–561. - PubMed
-
- Caine ED, Shoulson I. 1983. Psychiatric syndromes in Huntington’s disease. Am J Psychiatry. 140:728–733. - PubMed
-
- Duff K, Paulsen JS, Beglinger LJ, et al. 2007. Psychiatric symptoms in Huntington’s disease before diagnosis: the Predict-HD study. Biol Psychiatry. 62:1341–1346. - PubMed
-
- Folstein S, Abbott MH, Chase GA, et al. 1983. The association of affective disorder with Huntington’s disease in a case series and in families. Psychol Med. 13:537–542. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous